Cargando…
Hydroxyl safflower yellow B combined with doxorubicin inhibits the proliferation of human breast cancer MCF-7 cells
Doxorubicin (DOX) is currently the preferred chemotherapeutic agent for breast cancer, and hydroxyl safflower yellow B (HSYB) has a tumor growth-inhibiting activity. The present study aimed to investigate the effects of HSYB combined with DOX on the proliferation of human breast cancer MCF-7 cells a...
Autores principales: | Lin, Kehao, Qin, Ze, Qu, Chuanjun, Chen, Xiaoyu, Jiang, Qingling, Li, Minjing, Zheng, Qiusheng, Li, Defang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025109/ https://www.ncbi.nlm.nih.gov/pubmed/33850567 http://dx.doi.org/10.3892/ol.2021.12687 |
Ejemplares similares
-
Antitumor Proliferation and Related Mechanism of Ultrasound Irradiation Combined with Safflower Yellow
por: Li, Gen, et al.
Publicado: (2022) -
Antioxidant and Anti-Inflammatory Properties of Hydroxyl Safflower Yellow a in Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials
por: Fu, Shunlian, et al.
Publicado: (2022) -
Retracted: Antitumor Proliferation and Related Mechanism of Ultrasound Irradiation Combined with Safflower Yellow
por: Neuroscience, Computational Intelligence and
Publicado: (2022) -
Pharmacological Activities of Safflower Yellow and Its Clinical Applications
por: Chen, Yan, et al.
Publicado: (2022) -
Ailanthone Inhibits Cell Proliferation in Tongue Squamous Cell Carcinoma via PI3K/AKT Pathway
por: Wang, Shuhan, et al.
Publicado: (2022)